Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.20.2
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues:        
Total revenues $ 1,120 $ 947 $ 3,781 $ 2,394
Operating expenses:        
Cost of goods sold 683 188 1,081 738
Research and development 1,562 1,619 5,846 5,370
Selling, general and administrative 3,549 3,023 10,137 9,336
Total operating expenses 5,794 4,830 17,064 15,444
Loss from operations (4,674) (3,883) (13,283) (13,050)
Other expense:        
Interest expense, net (246) (238) (718) (737)
Non-cash gain (loss) on changes in the fair value of warrants 0 1,041 (923) 1,066
Gain on debt extinguishment 0 291 0 226
Other income (expense), net (12) (14) (233) (22)
Other income (expense), net (258) 1,080 (1,874) 533
Net loss and comprehensive loss $ (4,932) $ (2,803) $ (15,157) $ (12,517)
Basic and diluted net loss per common share $ (0.05) $ (0.18) $ (0.17) $ (0.89)
Weighted average shares used in computing basic and diluted net loss per common share 97,906 15,517 91,848 14,112
License revenue        
Revenues:        
Total revenues $ 0 $ 0 $ 6 $ 313
Product revenue        
Revenues:        
Total revenues 102 190 427 811
Grant revenue        
Revenues:        
Total revenues $ 1,018 $ 757 $ 3,348 $ 1,270